FDA review of dupilumab for chronic spontaneous urticaria

Published Date: 13 Mar 2023

The FDA approval request for CSU is based on data from a pair of Phase 3 trials in two different populations.

Read Full News

Latest News

New Zealand Detects First H5N1 Bird Flu Case, Starts Vaccination Of Endangered Species

New Zealand reported its first case of the deadly H5N1 bird flu after a migratory seabird found on a beach near the capital, Wellington, tested positive, ⁠Biosecurity...

Clean Catheterization Matches Sterile for Related UTI Risk

A clean bladder catheterization technique is as effective as a sterile method.

Immunosuppression Shows No Survival Benefit in Nephropathy

Escalating immunosuppressive therapy is not associated with improved renal or patient survival in rapidly progressive secondary IgA nephropathy, a Spanish study finds.

Patients With Dermatomyositis May Develop Heart Rate Issues

A small subset of patients — primarily women — with dermatomyositis may develop postural orthostatic tachycardia syndrome years later, a study finds.

Weighted Flare Score Predicts Organ Damage Risk in Lupus

A novel weighted flare score for systemic lupus erythematosus identifies high-risk disease flares, which are linked to the risk for subsequent organ damage.

Which Factors Affect Quality of Life in Chronic Pruritus

Daily itch duration, sleep disturbance, scratching frequency, and average itch intensity mediate the link between disease severity and quality-of-life impairment in patients with pruritic dermatoses.

Todays Updates

Virtual Help Doubles Cancer Patients’ Smoking Quit Rate

Programs offering telehealth counseling and nicotine replacement products should be part of routine oncology care, researchers say.

MRD Tied to PFS in Lymphoma Patients on Epcoritamab

Researchers evaluate minimal residual disease status in 128 adults with relapsed or refractory follicular lymphoma treated with epcoritamab.

Germline Profiling May Improve Risk Stratification in t-MNs

A new study explores whether germline profiling could refine the subclassification and prognosis of therapy-related myeloid neoplasms beyond treatment history alone.

Todays Updates

Virtual Help Doubles Cancer Patients’ Smoking Quit Rate

Programs offering telehealth counseling and nicotine replacement products should be part of routine oncology care, researchers say.

MRD Tied to PFS in Lymphoma Patients on Epcoritamab

Researchers evaluate minimal residual disease status in 128 adults with relapsed or refractory follicular lymphoma treated with epcoritamab.

Germline Profiling May Improve Risk Stratification in t-MNs

A new study explores whether germline profiling could refine the subclassification and prognosis of therapy-related myeloid neoplasms beyond treatment history alone.

Latest News

New Zealand reported its first case of the deadly H5N1 bird flu after a migratory seabird found on a beach near the capital, Wellington, tested positive, ⁠Biosecurity...

A clean bladder catheterization technique is as effective as a sterile method.

Escalating immunosuppressive therapy is not associated with improved renal or patient survival in rapidly progressive secondary IgA nephropathy, a Spanish study finds.

A small subset of patients — primarily women — with dermatomyositis may develop postural orthostatic tachycardia syndrome years later, a study finds.

A novel weighted flare score for systemic lupus erythematosus identifies high-risk disease flares, which are linked to the risk for subsequent organ damage.

Daily itch duration, sleep disturbance, scratching frequency, and average itch intensity mediate the link between disease severity and quality-of-life impairment in patients with pruritic dermatoses.

News All Time

Risk Stratification May ID Paraneoplastic Dermatomyositis

Paraneoplastic disease develops in a small proportion of patients with dermatomyositis but occurs mainly among those classified into the high-risk group per international risk stratification criteria.

A New Class of Therapeutics Could End Immunosuppressants

Amid growing evidence and a Nobel Prize win, research on regulatory T cells could transform treatment for autoimmune disease and transplant rejection, among many other conditions.

FDA Awards Breakthrough Status to Second Biologic for CLE

A faster review means there may soon be a novel therapy for the skin manifestations of lupus for the first time in a half-century.

Physical, Mental Factors Decrease COPD Inhaler Technique

Breath holding optimizes inhaler use regardless of dexterity or cognition challenges.

Does Cancer Death Risk Increase After Transplantation?

De novo cancer may double the risk for long-term mortality among solid organ transplantation recipients, a population-based study shows.

Elevated Interferon Alfa May Reveal Sjögren Disease Subtype

Elevated interferon alfa levels mark a subgroup of Sjögren disease, revealing immune changes years before diagnosis, and mice studies mirror these findings.

Cancer Recurrence: What Awakens Dormant Tumor Cells?

Emerging therapies target dormant tumor cells and their microenvironment to delay or prevent metastatic recurrence after successful cancer treatment.

Autoimmune Diseases Respond to Teclistamab but With Risks

Teclistamab may have potential for clinical responses in patients with refractory autoimmune diseases; however, cytokine release syndrome and infections occur frequently.

Expanded Pediatric Use for Roflumilast Under FDA Review

If approved, topical roflumilast 0.05% will be approved for treating atopic dermatitis down to age 3 months.

Model Spots Kids With Anaphylaxis Who Do Not Require ED Care

A prediction model identifies children with anaphylaxis who are at a low risk of requiring additional epinephrine and may safely avoid visits to the emergency department.

What's Really Killing Patients With Late-Stage PD?

A decade-long study finds aspiration pneumonia as the leading cause of death in late-stage Parkinson's disease, and worsening motor function, cognition, and depression predict a higher risk for death.

Inside Isolation Units for Highly Contagious Diseases

The Spanish model highlights the infrastructure, training, and containment measures required for high-risk infectious disease care.

Lower Breathing Pressure Tied to Complications in Preemies

In premature babies, lower breathing pressure at birth is linked to a higher likelihood of needing a breathing tube and later lung and eye complications.

Education Nudges Patients With CKD Away From Haemodialysis

Structured predialysis education may help patients with chronic kidney disease stages 4 and 5 to choose peritoneal dialysis over haemodialysis, a Polish study finds.

Trump CDC Nominee Schwartz Set for July 15 US Senate Confirmation Hearing

Erica Schwartz, President Donald Trump's nominee to lead the U.S. Centers for Disease Control and Prevention, will appear before the Senate Committee on Health, Education,...

Children With Sesame Allergy Often Tolerate Intact Seeds

Most children with sesame allergy who develop reactions to concentrated sesame products tolerate whole seeds during supervised oral food challenge, supporting individualized dietary counseling.

Recommended News For You

Study: Pre-operative THP leads to pCR in 64% of early-stage HER2+ ER- breast cancer patients

Routine breast cancer screening can bring better outcomes for patients

Prostate cancer screening seems to be improved by PSA, biomarker testing, and MRI combined.

TRK Inhibitor Active in Treatment-Refractory Glioblastoma

Serious Potato Chip Recall; Taylor Swift $$ for Hospitals; Hantavirus Outbreak Ends

Timely ‘Nudges’ Help Spur Talks on Patient Care Goals

Vistagen's Anxiety Disorder Drug Misses Main Goal in Late-stage Trial, Shares Plummet

Recommended Articles For You

How Digital Innovation and AI-Powered Case Studies are Revolutionizing Oncology Education? 

Unlocking the Potential of Immune Checkpoint Inhibitors: A Pioneering Case Series on the Role of Immunotherapy in Microsatellite-Instability-High Colorectal Cancer 

Decoding the Padua Score to Prevent Blood Clots in High-Risk Patients 

Beyond the Brain Fog: The Complex Neurological Challenges and Therapeutic Advances 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

FDA Approves Orca‑T, a Next‑Gen HSCT to Reduce GVHD

2.

According to a study, white Americans are overdiagnosing melanoma at an alarming rate.

3.

Home Screening Appeals to Women Facing Healthcare Barriers

4.

Tumor characteristics found to differ for melanomas in children, teens and young adults

5.

Preferred and Actual Location of Death Often Don't Match for Young Cancer Patients

1.

Progressive Models in Hematology for Healthcare Excellence

2.

Environmental Carcinogen Exposure Risk Modeling: Current Evidence and Clinical Implications

3.

Liquid Biopsy in SCLC: cfDNA Profiling for Diagnosis and Treatment Monitoring

4.

Chloride Test in HCC: Diagnostic Utility, Prognostic Role, and Emerging Insights

5.

CAR T-Cell Therapy: Revolutionizing Hematologic Malignancies

1.

Asian Symposium on Advancement in Hematology and Oncology

2.

Asian Symposium on Advancement in Hematology and Oncology

3.

Asian Symposium on Advancement in Hematology and Oncology

4.

International Cancer Conference

5.

Asian Symposium on Advancement in Hematology and Oncology

1.

Evolution in Treatment and Diagnosis of Lung Cancer- An Initiative from Manipal Hospitals

2.

Molecular Contrast: EGFR Axon 19 vs. Exon 21 Mutations - Part III

3.

An Intro to The Multifaceted Advantages of CDK4/6 Inhibitors in HR+/HER2- Advanced Breast Cancer Clinical Studies.

4.

Targeting Oncologic Drivers with Dacomitinib: Further Discussion on Lung Cancer Treatment

5.

Treatment Sequencing Strategies in ALK + NSCLC Patients with CNS Diseases - Part II

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot